Atlas Trials

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

Clinical trial NCT00049452 · COMPLETED

Trial details

NCT number
NCT00049452
Sponsor
Herbert Irving Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerOsteoporosis
Start date
2001-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.